HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Photoimmunotheranostic agents for triple-negative breast cancer diagnosis and therapy that can be activated on demand.

Abstract
Triple-negative breast cancer (TNBC) is a heterogeneous disease in which the tumors do not express estrogen receptor (ER), progesterone receptor (PgR) or human epidermal growth factor receptor 2 (HER2). Classical receptor-targeted therapies such as tamoxifen or trastuzumab are therefore unsuitable and combinations of surgery, chemotherapy and/or radiotherapy are required. Photoimmunotheranostics is a minimally invasive approach in which antibodies deliver nontoxic photosensitizers that emit light to facilitate diagnosis and produce cytotoxic reactive oxygen species to induce apoptosis and/or necrosis in cancer cells. We developed a panel of photoimmunotheranostic agents against three TNBC-associated cell surface antigens. Antibodies against epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule (EpCAM) and chondroitin sulfate proteoglycan 4 (CSPG4) were conjugated to the highly potent near-infrared imaging agent/photosensitizer IRDye®700DX phthalocyanine using SNAP-tag technology achieving clear imaging in both breast cancer cell lines and human biopsies and highly potent phototherapeutic activity with IC50values of 62-165 nM against five different cell lines expressing different levels of EGFR, EpCAM and CSPG4. A combination of all three reagents increased the therapeutic activity against TNBC cells by up to 40%.
AuthorsManal Amoury, Dirk Bauerschlag, Felix Zeppernick, Verena von Felbert, Nina Berges, Stefano Di Fiore, Isabell Mintert, Andreas Bleilevens, Nicolai Maass, Karen Bräutigam, Ivo Meinhold-Heerlein, Elmar Stickeler, Stefan Barth, Rainer Fischer, Ahmad Fawzi Hussain
JournalOncotarget (Oncotarget) Vol. 7 Issue 34 Pg. 54925-54936 (Aug 23 2016) ISSN: 1949-2553 [Electronic] United States
PMID27448975 (Publication Type: Journal Article)
Chemical References
  • CSPG4 protein, human
  • Chondroitin Sulfate Proteoglycans
  • Epithelial Cell Adhesion Molecule
  • IRDye700DX N-hydroxysuccinimide ester
  • Immunoconjugates
  • Indoles
  • Isoindoles
  • Membrane Proteins
  • Organosilicon Compounds
  • Photosensitizing Agents
  • Recombinant Fusion Proteins
  • Single-Chain Antibodies
  • O(6)-benzylguanine
  • Guanine
  • ErbB Receptors
  • phthalocyanine
Topics
  • Cell Line, Tumor
  • Cell Survival (drug effects, radiation effects)
  • Chondroitin Sulfate Proteoglycans (immunology, metabolism)
  • Epithelial Cell Adhesion Molecule (immunology, metabolism)
  • ErbB Receptors (immunology, metabolism)
  • Female
  • Guanine (analogs & derivatives, chemistry)
  • Humans
  • Immunoconjugates (chemistry, therapeutic use)
  • Indoles (chemistry, therapeutic use)
  • Isoindoles
  • Light
  • MCF-7 Cells
  • Membrane Proteins (immunology, metabolism)
  • Microscopy, Confocal
  • Organosilicon Compounds (chemistry, therapeutic use)
  • Photochemotherapy (methods)
  • Photosensitizing Agents (chemistry, therapeutic use)
  • Recombinant Fusion Proteins (chemistry)
  • Single-Chain Antibodies (chemistry, immunology)
  • Triple Negative Breast Neoplasms (diagnosis, drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: